Chronic kidney disease is the most common serious illness of older cats. The Cornell Feline Health Center estimates that roughly one in three cats will eventually develop some form of CKD, and prevalence in cats over the age of 15 climbs well above 30 percent in large epidemiological studies. Because cats are superb at hiding illness, the disease is frequently diagnosed only when two-thirds of kidney function is already gone. The encouraging news is that CKD, once identified, is one of the most manageable chronic diseases in feline medicine. Cats diagnosed in the early stages often live comfortably for years with the right monitoring, diet, and medications.
What Chronic Kidney Disease Actually Is
Healthy kidneys filter blood, maintain hydration, balance electrolytes, regulate blood pressure, control acid-base status, and produce hormones that stimulate red blood cell production. In CKD, nephrons — the microscopic filtering units of the kidney — are progressively and irreversibly lost. The remaining nephrons compensate by working harder, which is why outward symptoms appear late. By the time a cat looks unwell, both kidneys have usually lost a substantial portion of their functional tissue. The International Renal Interest Society (IRIS) defines CKD as kidney damage or reduced function that has been present for at least three months, distinguishing it from acute kidney injury, which comes on suddenly and may be reversible.
Why Cats Are So Prone to It
Multiple factors combine to make cats particularly vulnerable. Merck Veterinary Manual and the American Association of Feline Practitioners (AAFP) cite advancing age, chronic dehydration driven by a low thirst drive, dental disease and the bacteremia that accompanies it, previous episodes of acute kidney injury, high blood pressure, and certain infectious or inflammatory conditions. Breeds such as Persians, Maine Coons, Abyssinians, Siamese, and Russian Blues also have higher reported rates, and Persians in particular carry inherited polycystic kidney disease. In most cats, however, no single cause is identified and the disease is labeled idiopathic.
The Early Signs Most Owners Miss
The classic textbook signs of CKD — increased thirst, increased urination, weight loss, and decreased appetite — are reliable but generally appear only when function is already significantly reduced. Cornell and the ISFM consensus guidelines on CKD highlight subtler early changes that tend to show up first:
- Drinking noticeably more water, emptying the bowl more often, or seeking water from faucets and glasses.
- Larger or more frequent clumps in the litter box, urine that feels lighter in color, or trips to the box that have increased in number.
- Gradual weight loss over months, especially along the spine and over the hips, often without an obvious change in appetite.
- Pickier eating — the cat sniffs food, turns away, or takes a few bites and leaves.
- A duller, unkempt coat and reduced grooming.
- Intermittent vomiting, bad breath with an ammonia-like smell, or new constipation.
- Lower energy, more sleeping, and less interest in play or interaction.
Any combination of these changes in a cat over the age of about seven should prompt a full physical exam and screening bloodwork. AAFP's senior care guidelines recommend wellness screening every six to twelve months once cats reach the mature and senior life stages, precisely because catching CKD early changes outcomes.
How Veterinarians Diagnose and Stage CKD
Diagnosis combines bloodwork, urine testing, and blood pressure measurement. The three values that matter most are:
- Creatinine, a muscle breakdown product normally cleared by the kidneys.
- SDMA (symmetric dimethylarginine), a newer marker that rises earlier than creatinine — often when as little as 25 percent of kidney function is lost — and is validated against gold-standard GFR measurement.
- Urine specific gravity and urine protein-to-creatinine ratio, which show how well the kidneys are concentrating urine and whether protein is leaking through damaged filters.
Once CKD is confirmed, IRIS guidelines stage the disease from 1 (earliest, minimal clinical signs) to 4 (severe, uremic) based on creatinine and SDMA, and then substage it by urine protein loss and blood pressure. Staging matters because the recommended treatment differs meaningfully at each level, and because accurate staging gives owners a realistic picture of what to expect over the coming months and years.
Evidence-Based Management
No treatment reverses established CKD, but several interventions have strong evidence for slowing progression and improving quality of life. The core pillars, drawn from the IRIS treatment recommendations and the 2016 ISFM consensus guidelines, are:
A therapeutic renal diet. Controlled-protein, restricted-phosphorus, omega-3-enriched veterinary renal diets are the single intervention with the best-documented survival benefit. A landmark 2006 randomized controlled trial by Ross and colleagues, published in the Journal of the American Veterinary Medical Association, found that cats with IRIS stage 2 to 3 CKD fed a renal diet had significantly fewer uremic crises and lived, on average, more than twice as long as cats fed a standard maintenance diet. Transitioning slowly and offering multiple flavors and textures usually gets reluctant cats on board.
Phosphorus control. Elevated phosphorus drives further kidney damage and is independently associated with shorter survival. When a renal diet alone is not enough, oral phosphate binders given with meals bring phosphorus into IRIS target ranges.
Hydration support. Wet food, multiple fresh water stations, pet fountains, and — in later stages — subcutaneous fluids at home can offset the cat's weak thirst drive. Cornell and AAFP both emphasize that dehydration accelerates CKD progression and worsens nausea.
Blood pressure management. Up to 60 percent of CKD cats develop hypertension, which can blind a cat overnight by causing retinal detachment. The calcium-channel blocker amlodipine is the first-line feline antihypertensive and is highly effective. Yearly (or more frequent) blood pressure checks are standard of care.
Proteinuria reduction. Cats with significant urine protein loss typically receive an ACE inhibitor such as benazepril or the angiotensin receptor blocker telmisartan, both shown in controlled trials to reduce proteinuria in feline CKD.
Nausea and appetite support. Maropitant (Cerenia) for nausea and mirtazapine (including the transdermal form, Mirataz, which is FDA-approved for appetite stimulation in cats) help cats eat and feel better, which in turn protects muscle mass and quality of life.
Anemia management. In advanced CKD, reduced erythropoietin production causes anemia. Darbepoetin injections can restore red blood cell counts and dramatically improve energy in selected patients.
What the Day-to-Day Looks Like at Home
For most owners, living with a CKD cat becomes a steady routine rather than a crisis. Feed the prescribed diet consistently. Place extra water bowls around the home and consider a pet fountain — many cats drink substantially more from running water. Weigh your cat monthly on a kitchen or baby scale; slow, ongoing weight loss is often the earliest sign that a treatment plan needs adjusting. Watch the litter box. Keep scheduled rechecks, typically every three to six months in stable cats and more often in advanced stages. If your vet prescribes subcutaneous fluids, a short hands-on lesson almost always makes a procedure that sounds intimidating become routine within a week or two.
Prognosis and the Importance of Catching It Early
Survival in CKD varies widely by stage at diagnosis. Large retrospective studies, including work by Boyd and colleagues, have reported median survival times of roughly three years for cats diagnosed in IRIS stage 2, about 1.5 years for stage 3, and substantially shorter for stage 4. Individual cats, particularly those caught early and kept well managed, can live considerably longer. The single most powerful thing an owner can do is to screen older cats annually — ideally twice a year once they turn ten — so that CKD is identified in stage 1 or early stage 2, when dietary and medical intervention can change the trajectory of the disease.